Clincosm LogoSign in Get a demo

Rheumatoid Arthritis

Showing NaN - NaN of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial in Germany, Poland (MR Prednisone, IR Prednisone, Placebo - MR Prednisone)

Completed
Has Results
  • Rheumatoid Arthritis
  • MR Prednisone
  • +3 more
  • Aachen, Germany
  • +23 more
Jun 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Mavrilimumab 10 mg, Mavrilimumab 30 mg, Mavrilimumab 50 mg)

Completed
Has Results
  • Rheumatoid Arthritis
  • Mavrilimumab 10 mg
  • +4 more
  • Plovdiv, Bulgaria
  • +55 more
Mar 23, 2018

Rheumatoid Arthritis Trial in Worldwide (PF-06438179, Infliximab)

Completed
Has Results
  • Rheumatoid Arthritis
  • PF-06438179
  • Infliximab
  • Birmingham, Alabama
  • +183 more
Apr 30, 2018

Rheumatoid Arthritis Trial in Poland (Tocilizumab)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Bytom, Poland
  • +3 more
Feb 7, 2018

Rheumatoid Arthritis Trial in Worldwide (GP2013 - A Proposed biosimilar rituximab, Originator rituximab - Rituxan ® or MabThera

Completed
Has Results
  • Rheumatoid Arthritis
  • GP2013 - A Proposed biosimilar rituximab
  • Originator rituximab - Rituxan ® or MabThera ®
  • Huntsville, Alabama
  • +64 more
Nov 30, 2017

Rheumatoid Arthritis Trial in Worldwide (Tregalizumab, Placebo)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Paradise Valley, Arizona
  • +83 more
Jul 25, 2017

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, , hydroxychloroquine)

Completed
Has Results
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +195 more
Jul 7, 2017

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Etanercept, Methotrexate)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +256 more
Jun 28, 2017

Rheumatoid Arthritis Trial in Worldwide (Tocilizumab, Placebo to tocilizumab, Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +235 more
Jun 28, 2017

Rheumatoid Arthritis Trial in Worldwide (Etanercept, Tocilizumab)

Completed
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +427 more
Jun 13, 2017

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Placebo (for sarilumab), Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +261 more
Jun 27, 2017

Rheumatoid Arthritis Trial in Worldwide (sarilumab SAR153191 (REGN88), tocilizumab, hydroxychloroquine)

Completed
Has Results
  • Rheumatoid Arthritis
  • sarilumab SAR153191 (REGN88)
  • +7 more
  • Huntsville, Alabama
  • +77 more
Jun 23, 2017

Rheumatoid Arthritis Trial in Worldwide (sarilumab SAR153191 (REGN88))

Completed
Has Results
  • Rheumatoid Arthritis
  • sarilumab SAR153191 (REGN88)
  • Gilbert, Arizona
  • +27 more
May 23, 2017

Rheumatoid Arthritis Trial in Worldwide (Bimekizumab, Certolizumab Pegol, Placebo)

Completed
  • Rheumatoid Arthritis
  • Bimekizumab
  • +2 more
  • Praha 7, Czechia
  • +20 more
May 29, 2017

Rheumatoid Arthritis Trial in Worldwide (Rituximab, Methotrexate, Methylprednisolone)

Completed
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +91 more
Jan 23, 2017

Inflammation, Rheumatoid Arthritis Trial in Brussels, Warszawa (anti-IL-20, )

Completed
  • Inflammation
  • Rheumatoid Arthritis
  • Brussels, Belgium
  • +1 more
Feb 8, 2017

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0114-0006, )

Completed
  • Inflammation
  • Rheumatoid Arthritis
  • Plovdiv, Bulgaria
  • +32 more
Feb 6, 2017

Rheumatoid Arthritis Trial in Worldwide (MLTA3698A, adalimumab, leflunomide)

Completed
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +66 more
Nov 1, 2016

Rheumatoid Arthritis Trial in Worldwide (P38 Inhibitor (4) 150mg, P38 Inhibitor (4) 25mg, P38 Inhibitor (4) 300mg)

Completed
  • Rheumatoid Arthritis
  • P38 Inhibitor (4) 150mg
  • +5 more
  • Birmingham, Alabama
  • +113 more
Nov 1, 2016

Rheumatoid Arthritis Trial in Worldwide (Cyclophosphamide, Methotrexate, Placebo Cyclophosphamide)

Completed
  • Rheumatoid Arthritis
  • Darlinghurst, Australia
  • +32 more
Oct 29, 2016

Rheumatoid Arthritis Trial in Worldwide (Mavrilimumab 30 mg, Mavrilimumab 100 mg, Mavrilimumab 150 mg)

Completed
Has Results
  • Rheumatoid Arthritis
  • Mavrilimumab 30 mg
  • +3 more
  • Ciudad Autonoma de Buenos Aire, Argentina
  • +42 more
Aug 3, 2016

Rheumatoid Arthritis Trial in Worldwide (AK106-001616, Active comparator)

Completed
  • Rheumatoid Arthritis
  • Hlucin, Czech Republic
  • +25 more
Jul 21, 2016

Rheumatoid Arthritis Trial in Worldwide (tocilizumab SC, tocilizumab IV, to tocilizumab SC)

Completed
Has Results
  • Rheumatoid Arthritis
  • tocilizumab SC
  • +4 more
  • Huntsville, Alabama
  • +216 more
May 11, 2016

Rheumatoid Arthritis Trial in Worldwide (Placebo, CNTO 6785 200 mg, CNTO 6785 100 mg)

Completed
  • Rheumatoid Arthritis
  • Placebo
  • +5 more
  • Buenos Aires, Argentina
  • +33 more
Feb 3, 2016

Rheumatoid Arthritis Trial in Worldwide (Abatacept, Methotrexate, Abatacept )

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +72 more
Dec 9, 2015